Research
Hormonal
Semaglutide leads to significantly higher overall weight loss compared to placebo and most other comparison treatments.
Semaglutide may be a viable option for practitioners looking to support weight loss in obese and overweight patients.
StrongSupportsmedium confidence
All studies reviewed identified that study participants on semaglutide experienced a significantly higher overall weight loss than placebo and most other comparison treatments.
Why this rating
The claim is based on a review of multiple studies.
Source
Semaglutide for the treatment of obesity – a review
Abubakar Bham et al. · World Family Medicine Journal /Middle East Journal of Family Medicine · 2021
reviewCited 2×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →